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Abstract
Background. Greater levels of insight may be linked with depressive symptoms among patients
with schizophrenia, however, it would be useful to characterize this association at symptom-
level, in order to inform research on interventions.
Methods. Data on depressive symptoms (Calgary Depression Scale for Schizophrenia) and
insight (G12 item from the Positive and Negative Syndrome Scale) were obtained from
921 community-dwelling, clinically-stable individuals with a DSM-IV diagnosis of schizo-
phrenia, recruited in a nationwide multicenter study. Network analysis was used to explore the
most relevant connections between insight and depressive symptoms, including potential
confounders in the model (neurocognitive and social-cognitive functioning, positive, negative
and disorganization symptoms, extrapyramidal symptoms, hostility, internalized stigma, and
perceived discrimination). Bayesian network analysis was used to estimate a directed acyclic
graph (DAG) while investigating the most likely direction of the putative causal association
between insight and depression.
Results. After adjusting for confounders, better levels of insight were associated with greater
self-depreciation, pathological guilt, morning depression and suicidal ideation. No difference
in global network structure was detected for socioeconomic status, service engagement or
illness severity. The DAG confirmed the presence of an association between greater insight and
self-depreciation, suggesting the more probable causal direction was from insight to depressive
symptoms.
Conclusions. In schizophrenia, better levels of insightmay cause self-depreciation and, possibly,
other depressive symptoms. Person-centered and narrative psychotherapeutic approaches may
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Highlights
• Better insight seems associated with depressive symptoms in schizophrenia.
• Network analyses were used to explore this association in a large sample.
• Insight was associated with self-depreciation, guilt, and suicidal ideation.
• Although cross-sectional, data suggest causal direction from insight to depression.
Introduction
Better levels of insight are associated with the presence of depressive
symptoms among patients with schizophrenia, but it would be
useful to understand the relationship at symptom level.
Lack of awareness into the illness is a common feature of
schizophrenia that hampers adherence to treatment and compli-
cates the clinical course [1, 2]. Conversely, having good levels of
insight may also bring about negative consequences, namely
depressive symptoms [3] or even suicidal ideation [4, 5]. This
phenomenon has been termed the “insight paradox” and possibly
results from the painful realization of the implications and conse-
quences of suffering from a chronic and stigmatized illness. The
association between good insight and depression was examined by
different individual studies assessing patients at different stages of
the disorder [3, 4, 6–10]. Pooled results suggest that this phenom-
enon is complex and highly variable, both in terms of strength of the
association and underlying psychopathological mechanisms
[11]. Moreover, this relationship may depend on a number of
clinical, contextual, and cultural factors, such as socioeconomic
status, engagement with mental health services, stigmatization,
and severity of the illness [1, 6, 12, 13]. Moreover, several potential
confounders can be identified, for example, negative and positive
symptoms [14], hostility [15], cognitive abilities [16, 17], levels of
social cognition [18], and extrapyramidal side effects [19].
Besides clinical and sociodemographic variability, previous incon-
sistent findings could be also related tomethodological factors. Several
studies examining the relationship between insight and depression
examined relatively small sample sizes, and only few measured mul-
tiple confounders at once, thus possibly preventing the detection of
significant associations. To this end, the network approach to psycho-
pathology may offer a suitable approach to examine the associations
linking insight to specific depressive symptoms [20].
Given these premises, the aim of this study was to examine the
relationship between insight and depressive symptoms in a large
representative sample of patients with schizophrenia, using the
network approach to psychopathology. We hypothesized that
insight would be associated with self-depreciation and suicidal
ideation and that the most likely causal direction would be from
insight to depressive symptoms.
Methods
Study population
This is a reanalysis of data collected in the study by the Italian
Network for Research on Psychoses: a detailed description of the
study procedures is provided elsewhere [21]. Briefly, a large repre-
sentative sample of clinically stable, community-dwelling patients
aged 18–66 with a diagnosis of schizophrenia were recruited from
various outpatient units of 26 Italian university psychiatric clinics
andmental health departments. Clinical stability was defined as the
absence of variation of antipsychotic drug treatment and of
hospitalizations during the 3months before recruitment
[21]. Exclusion criteria were: presence of neurological disorders;
history of alcohol dependence or substance abuse in the past 6
months; moderate or severe mental retardation; and inability to
provide informed consent. The study was approved by the local
ethics committees and was conducted in accordance with the
Helsinki Declaration as revised in 1989.
Assessments
The study involved the collection of detailed sociodemographic and
clinical information. Briefly, the severity of depressive symptomswas
assessed with the Calgary Depression Scale for Schizophrenia
(CDSS) [22]. The scale comprises nine items, namely depression,
hopelessness, self-depreciation, guilty ideas of reference, pathologi-
cal guilt, morning depression, early wakening, suicide, and observed
depression. Insight was assessed using the G12 item of the Positive
and Negative Syndrome Scale (PANSS) [23]. The item rates the
severity of “lack of judgment and insight,” with higher scores indi-
cating lower levels of insight. Hostility was rated with the item P7,
where higher scores indicate greater hostility. PANSS factor scores
for the dimensions “disorganization” and “positive symptoms”were
calculated according to the 5-factor solution by Wallwork et al.
[24]. The severity of negative symptoms was assessed using the Brief
Negative SymptomScale (BNSS) and calculating scores for the “poor
emotional expression” and “avolition” factors [25]. Extrapyramidal
symptoms were assessed with the St. Hans Rating Scale (SHRS) total
score, converted in z-scores; higher scores indicate more severe
extrapyramidal symptoms [26]. Neurocognitive functions were
assessed using the measurement and treatment research to improve
cognition in schizophrenia (MATRICS) consensus cognitive battery
(MCCB) [27]. The composite score was calculated excluding the
Mayer–Salovey–Caruso Emotional Intelligence Test (MSCEIT)
score and adjusting for age and gender. Social cognition was assessed
with the “managing emotion” section of the MSCEIT, the Facial
Emotion Identification Test (FEIT) [28] and the Awareness of Social
Inference Test (TASIT) [29]. Data was reduced to two factors with
principal component analysis, with greater scores indicating better
social cognition abilities. Internalized stigma was assessed with the
Internalized Stigma of Mental Illness (ISMI) total score: higher
scores indicate greater levels of internalized stigma [30]. The Per-
ceived Devaluation and Discrimination Scale (PDD) [31] was used
to assess perceived discrimination, again, higher scores indicate
greater perceived discrimination. The Service Engagement Scale
measured the levels of engagement with mental health services;
higher scores indicating worse levels of engagement with services
[32]. Socioeconomic status was estimated with the Hollingshead
Index (HI) [33].
Data analyses
Depression is usually assessed by means of rating scale sum scores,
typically, the Calgary Depression Scale for Schizophrenia
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[19]. Despite its utility, this approach prevents from detecting
potential associations between contextual or clinical features and
specific depressive symptoms, which could represent elective tar-
gets for psychological [34–36] or pharmacological [37] interven-
tions against depression in schizophrenia. Whereas, network
analyses provide information on the relationship between individ-
ual symptoms of mental disorders by modeling their mutual rela-
tionship [20]. Network analyses allow to depict the interactions
between individual symptoms representing them as “nodes” that
are interconnected by “edges,” the latter representing the strength
of symptoms’ mutual interactions [38].
In the first analysis, we examined the network of depressive
symptoms comprising items from the CDSS and insight, rated by
the PANSS item G12. The network was estimated using the qgraph
1.6.5 package, with EBICglasso regularization [39]. The procedure
relies on the selection of the most meaningful partial correlations
between individual symptoms, represented as edges of varying
thickness. The network is visualized using the Fruchterman–Rein-
gold algorithm, which positions nodes with more relevant connec-
tions more centrally in the network. We report on the network
centralitymeasure of node strength, that is the sumof theweights of
all direct connections between a specific symptom and the others in
the network. Also, we highlight the shortest paths linking the node
of insight to those of depressive symptoms. Network accuracy was
estimated with: (a) estimation of the bootstrapped confidence
intervals of edge-weights from a nonparametric bootstrap proce-
dure (n =1,000); (b) estimation of the stability of node centrality
(strength index) from a case-drop bootstrap procedure (n =1,000).
Here, an increasing proportion of cases is subtracted from the
dataset, while re-estimating the network structure and centrality
indicesmultiple times. Node strength stability is represented graph-
ically and indexed by the Correlation Stability Coefficient (CS-C),
that is the maximum proportion of cases that can be dropped from
the sample with minimal impact on centrality indices. These pro-
cedures are implemented in the bootnet 1.3 package [39].
Second, we examined the effect of previously identified moder-
ators (i.e., effect modifiers) on the network of insight and depressive
symptoms [6]. The sample was subdivided based on a median split
of each moderating variable (HI scores for socioeconomic status,
SES scores for engagement with mental health services, and PANSS
total scores for illness severity) and the structures of the resulting
networks were compared. The package NetworkComparisonTest
2.2.1 provides information on the differences in global network
structure, global network strength and strength of individual edges,
based on a permutation test (n =1,000) [40].
Third, we examined whether the relationship between insight
and depressive symptoms would change after including con-
founders and putative mediators in the model. To this end, we
re-estimated the network structure after adding the following fac-
tors: PANSS factors for disorganized and positive symptoms,
PANSS item p7 for hostility, BNSS factors for negative symptoms,
neurocognitive and social cognition factors, ISMI total score for
internalized stigma, PDD score for perceived discrimination, and
SHRS score for the severity of extrapyramidal symptoms.
Fourth, we sought to determine the putative direction of the
causal relationship between insight and depression by reanalyzing
data of depressive symptoms and insight with a directed acyclic
graph (DAG). This is a recently developed addition to network
analyses based on a Bayesian approach. Unlike undirected net-
works, Bayesian DAGs have been developed to detect and represent
the most likely direction of the causal relationships between symp-
toms based on the conditional dependence between each couple of
variables, given the other variables in the network [41, 42]. For this
purpose, the package bnlearn 4.5 was used [43], following the
procedures described in a recent paper [42]. Briefly, the procedure
“learns” the structure of the network using a hill-climbing algo-
rithm that computes the structure of the directed network multiple
times (n =1,000 iterations) while computing a goodness-of-fit
index (i.e., Bayesian Information Criteria, BIC) for each edge. By
relying on a validated threshold-based method to optimize sensi-
tivity and specificity [44], a final, averaged network is selected. The
network retains only those edges and causal directions that appear
in a substantial proportion of the iterations, defined by the thresh-
old. For ease of interpretation, only those edges displaying the same
direction in 70% or more of the iterations were plotted as directed
(i.e., with arrows), while the remainder were plotted as undirected.
Moreover, the averaged network was plotted in two ways:
(a) weighting the thickness of each edge by its fitted regression
parameter, in order to display the magnitude and direction of the
connections between nodes and (b) weighting the thickness of each
edge by its arc strength, thus indicating the relative importance of
each edge in the network. Arc strength indicate the magnitude of
the corresponding BIC value for each edge; hence, a large negative
value for one edge suggests that removing it would significantly
worsen the network fitness.
All analyses were carried out in R version 3.6.1 The R code and
correlation matrices are available in the supplement for ease of
reproducibility.
Results
Network of insight and depressive symptoms
Table 1 reports the characteristics and rating scale scores of the
921 participants in the study. Three participants had missing data
for insight or depression scales. The network of depressive symp-
toms and insight contained 35 edges (Figure 1, weighted adjacency
matrix in Table S1). Depressive symptoms were highly intercon-
nected, and lack of insight was connected negatively with
(in decreasing order of edge weight) self-depreciation, guilty ideas
of reference, pathological guilt, and positively with early wakening.
This indicates that greater levels of insight were associated with
more severe depressive symptoms, with the exception of early
wakening. Lack of insight was the least central node in the network,
while depressed mood and hopelessness were the most central
(centrality plot is reported in Figure S1). The shortest paths between
insight and depressive symptoms are reported in Table S2. The link
between insight and self-depreciation was the shortest path to
hopelessness, suicide and observed depression. The network
appeared quite stable across bootstrap accuracy analyses, both in
terms of edge weights and node strength (Figures S2 and S3). The
case-drop procedure indicated that 80% of the sample could be
dropped without significantly affecting node strength.
Role of moderators
Socioeconomic status, service engagement and illness severity were
weakly correlated with nodes in the network (Table S3). We com-
pared the networks of insight and depressive symptoms between
subgroups of participants subdivided by different levels of the three
putative moderators. There were no significant differences in net-
work characteristics between participants with low versus high
socioeconomic status (406 versus 384 subjects, respectively; net-
work invariance test M = 0.17, p = 0.25; global strength invariance
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test S = 0.02, p = 0.93, Figures S4–S6) or subjects with low versus
high engagement with mental health services was (453 vs. 465 sub-
jects, respectively, network invariance testM =0.14, p =0.42; global
strength invariance test: low SES: 3.18, high SES: 3.64, S = 0.47, p =
0.06, Figures S7–S9). There were no significant differences in edges
linking insight with depressive symptoms (all p > 0.05). Lastly, there
were no significant global network differences comparing the net-
works of individuals with low versus high illness severity (451 vs.
458, respectively, network invariance testM =0.18, p = 0.07; global
strength invariance test S =0.30, p = 0.20, Figures S10–S12). How-
ever, among individuals with low severity, insight was negatively
connected with hopelessness (higher insight/greater hopelessness,
edge weight =0.027) and pathological guilt (edge weight =
0.10), while among individuals with higher severity insight did
not display connections with these nodes (p =0.04 and p =0.007,
respectively).
Extended network
After entering confounding factors in the network (Figure 2) insight
displayed negative edges with self-depreciation, morning depression
and pathological guilt, similar to the previous network, and, in
addition, with suicide (greater the levels of insight/more severe
depressive symptoms). Lack of insightwas also connected by positive
edges with hostility, disorganization and positive symptoms (PANSS
factors) and negative symptoms (BNSS factors), while it displayed
negligible or no connections with internalized stigma (ISMI), per-
ceived discrimination (PDD), social cognition and neurocognition.
Hostility was also positively connected with some depressive symp-
toms (guilty ideas of reference, early wakening, suicide). Results of
centrality analyses and network accuracy bootstrap analyses are
reported in the supplement (Figures S13–S15).
Directed acyclic graph
The procedure by [44] identified 0.466 as the optimal significance
threshold. Thus, edges appearing in 46.6% or more, of the boot-
strapped networks were retained in the averaged DAG of insight
and depressive symptoms; this corresponded to 21 edges (Figure 3).
In the DAGs (Figure 3) only those edges with an unequivocal
direction (70% or more iterations displaying the same direction)
were plotted as directed. The percentage of bootstrap iterations
reporting the same direction for each edge is reported in Table S4.
Higher levels of insight predicted higher levels of self-
depreciation (negative coefficient: 0.21) and lower levels of guilty
ideas of reference (positive coefficient: 0.06). The most likely direc-
tion of their causal relationship was from insight to depressive
symptoms (self-depreciation: 96%; guilty ideas of reference: 89%).
The rest of connections between depressive symptoms were all
positive, those with greater magnitude being from pathological guilt
to early awakening, from morning depression to suicide, from
insight to self-depreciation and from pathological guilt to self-
depreciation (Figure 3 and Table S4). The most important edges in
terms of arc strengths (fitness of the network model to data), were
from hopelessness to observed depression, from pathological guilt to
depression, from pathological guilt to guilty ideas of reference and
from depression to morning depression (Figure S16 and Table S4).
Discussion
The study examined the relationship between insight and depressive
symptoms in schizophrenia, a clinical phenomenon that has been
termed “insight paradox.”Having good insight is generally regarded
as a favorable clinical feature: nonetheless, patients with greater
awareness into their illness may present with depressive symp-
toms—a seemingly contradictory finding [8]. By relying on the
network approach to psychopathology and examining a large, rep-
resentative clinical sample of clinically stable patients, we highlighted
the associations between insight and specific depressive symptoms,
while accounting for the role ofmoderators and confounding factors.
The main finding is that good levels of insight were associated
with greater self-depreciation, as well as pathological guilt, morning
depression and suicide. The finding is in line with results from the
meta-analysis on this topic [11] and our previous study [6],
although we did not replicate the effects of illness severity, socio-
economic status and service engagement [6]. These results, how-
ever, extend previous findings by identifying which depressive
symptoms could derive from the acquisition of insight and detect-
ing the most probable direction of their causal relationship.
Table 1. Sample characteristics (n = 921).
Sociodemographic and clinical features
Gender (% males) 69.6
Age (years, meanSD) 40.2 10.7
Married (% yes) 7.8
Working (%yes) 29.2
Education (years, meanSD) 11.6 3.4
Hollingshead index (meanSD) 25.6 14.8






Suicide attempts (% yes) 17.1
Rating scales scores (meanSD)
CDSS total score 4.0 4.0
PANSS total score 75.5 23.0
PANSS positive factor 9.8 4.7
PANSS disorganization factor 8.56 3.80
PANSS item G12 3.18 1.62
PANSS item P7 1.71 1.11
BNSS poor emotional expressivity 12.8 8.0
BNSS avolition 20.7 9.6
Neurocognitive component 26.7 11.9
Social cognition factor 1 1.31 1.09




St. Hans rating scale (z-scores, median, range) 0.39 (0.44–5.47)
Abbreviations: BNSS, Brief Negative Symptom Scale; CDSS, Calgary Depression Scale for
Schizophrenia; ISMI, Internalized Stigma of Mental Illness; PDD, Perceived Devaluation and
Discrimination Scale; PANSS, Positive and Negative Syndrome Scale; SD, standard deviation.
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Results from the DAG of insight and depression are not directly
comparable with those from the undirected networks: among other
differences, DAGs cannot include feedback or feedforward loops,
and they are estimated differently [44]. Nonetheless, both analyses
identified a connection between increased insight and self-










































18: factor positive sx.
social cognition
13: social cognition fac.1
14: social cognition fac.2
stigma−related
11: internalized stigma (ISMI)
























self-depreciation, rather than vice versa. These results are in keep-
ingwith findings fromprospective studies: improvements of insight
predicted the future development of depressive symptoms in the
majority of works examining this issue [7, 45–49], while only one
detected a reciprocal putative causal direction [50]. These findings
have been interpreted according to a “defensive” role of low insight,
which would protect the individual against self-devaluation and
lowmood [11, 51, 52]. Importantly, the inclusion of other symptom
dimensions as confounders in our model did not affect the strength
and direction of such associations but, on the contrary led to detect
an additional connection with suicidal ideation. Thus, in order to
detect reliable associations between insight and depression, other
symptom dimensions and clinical features should be taken in
account [14, 16, 53, 54].
The association of better insight with self-depreciation may
reflect the dire psychological consequences of the subjective ill-
ness experience: several studies have shown that greater awareness
of one’s own mental illness can dampen self-esteem [8, 55–57] by
evoking a wide array of negative feelings: shame, loss, subjective
doubt, perceived burdensomeness, and guilt [58–62]. The degree
of identification with one’s illness (i.e., patient role) becomes
particularly problematic in the presence of stigma, either
endorsed by patients [63, 64] or by their relatives [65]. These
dynamics may pave the way to demoralization [66, 67], hopeless-
ness and suicidal ideation [4, 68, 69], unless individuals are helped
to come to terms with, andmake sense of their illness. To this end,
a person-centered approach, focused on the development of
metacognitive abilities and relying on a narrative approach has
yielded promising results for the improvement of insight without
lowering self-esteem [36, 70].
Finally, greater levels of insight were associated (in the adjusted
network, but not in the DAG) with higher morning depression, a
common sign of sleep disruption and/or neuroendocrine circadian
abnormalities across various psychiatric disorders [71]. In this light,
it should be recognized that not only psychosocial, but also biolog-
ical mechanismsmay underlie the relationship between insight and
specific depressive symptoms, as well as between other clinical
dimensions. Future studies are still needed to elucidate the differ-
ential mechanisms of symptom–symptom interaction.
This study is strengthened by a large, representative sample of
individuals suffering from schizophrenia and the use of state-of-the
art analytic techniques that are fit to describe complex dynamic
systems, such as psychopathology [72]. However, our findings need
to be weighed in the light of the study limitations. First, the PANSS
item used to rate insight is less detailed thanmultidimensional tools
[2]. Using the PANSS item instead of other instruments prevents
from making inferences on which sub-dimensions of insight are
linked with depressive symptoms (i.e., awareness of the illness, of
social consequences or perceived treatment need). Moreover, the
PANSS item rates “lack of judgment” besides insight [23]: this
relative lack of specificity may have led to underestimate, or con-
found the magnitude of the association with depressive symptoms.
Future studies should encompass multidimensional assessment
tools in order to provide more specific information that may guide
psychoeducational or psychotherapeutic interventions. Second,
even if the DAG provides an indication on the most likely causal
direction of the symptom interactions, it is based on cross-sectional
data, calling for caution when interpreting this finding. Whereas,
future longitudinal network analyses may be particularly suited to
re-examine this issue, possibly modeling the short-term interac-
tions between insight and depressive symptoms [73]. Third,
although we assessed a wide range of clinical dimensions, we
did not assess specific psychological features that are likely to play
a role in the association between insight and depression, such as
shame, self-esteem, or illness-related appraisals. Their inclusion
in the model may further contribute to map the dynamics at play.
Fourth, comparing the network for different levels of illness
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additional edges, in particular of negative sign, must be inter-
preted with caution. Future studies on this issue should also take
advantage of a recently-introduced approach, namely moderated
network models [75].
In conclusion, greater levels of insight can lead to the develop-
ment of self-reproach, guilt or even suicidal ideation among patients
with schizophrenia. Clinicians should be aware of the delicacy of
discussing issues related to diagnostic and prognostic issues with
patients, while actively investigating self-esteem, stigmatization and
suicidal ideation among individuals with preserved insight [4].
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